Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital Central California
mi
from
Madera, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital Central California
mi
from
Madera, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
mi
from
Denver, CO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Yale University
mi
from
New Haven, CT
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Childrens National Medical Center
mi
from
Washington,
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Broward Health Medical Center
mi
from
Fort Lauderdale, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Broward Health Medical Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Lee Memorial Health System
mi
from
Fort Myers, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Lee Memorial Health System
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Florida
mi
from
Gainesville, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Memorial Healthcare System - Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Memorial Healthcare System - Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Baptist Hospital of Miami
mi
from
Miami, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Baptist Hospital of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Miami Children's Hospital
mi
from
Miami, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Miami Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Joseph Children's Hospital of Tampa
mi
from
Tampa, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Joseph Children's Hospital of Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Mary's Hospital
mi
from
West Palm Beach, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Mary's Hospital
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Augusta University
mi
from
Augusta, GA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Memorial Health University Medical Center
mi
from
Savannah, GA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Tripler Army Medical Center
mi
from
Honolulu, HI
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Tripler Army Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Univ of Hawaii
mi
from
Honolulu, HI
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Univ of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Luke's Mountain States Tumor Institute
mi
from
Boise, ID
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Luke's Mountain States Tumor Institute
mi
from
Boise, ID
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Univ of Illinois
mi
from
Chicago, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Loyola University Medical Center
mi
from
Maywood, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Advocate Lutheran General Hospital
mi
from
Park Ridge, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Advocate Lutheran General Hospital
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Jude Midwest Affiliate
mi
from
Peoria, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Jude Midwest Affiliate
mi
from
Peoria, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Southern Illinois University
mi
from
Springfield, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Southern Illinois University
mi
from
Springfield, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Vincent Hospital and Health Services
mi
from
Indianapolis, IN
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Vincent Hospital and Health Services
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Kentucky
mi
from
Lexington, KY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Kosair Children's Hospital
mi
from
Louisville, KY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital-Main Campus
mi
from
New Orleans, LA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital-Main Campus
mi
from
New Orleans, LA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Eastern Maine Medical Center
mi
from
Bangor, ME
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Maine Children's Cancer Program
mi
from
Scarborough, ME
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Maine Children's Cancer Program
mi
from
Scarborough, ME
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Floating Hospital for Children at Tufts Medical Center
mi
from
Boston, MA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Floating Hospital for Children at Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials